Market Insight: CareTrust REIT Inc (CTRE)’s Notable Gain%, Closing at $34.54

The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.

In the latest session, CareTrust REIT Inc (NYSE: CTRE) closed at $34.54 up 0.67% from its previous closing price of $34.31. In other words, the price has increased by $0.67 from its previous closing price. On the day, 2.0 million shares were traded. CTRE stock price reached its highest trading level at $34.73 during the session, while it also had its lowest trading level at $34.1069.

Ratios:

For a deeper understanding of CareTrust REIT Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 24.86 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 25.27. For the most recent quarter (mrq), Quick Ratio is recorded 6.87 and its Current Ratio is at 6.87. In the meantime, Its Debt-to-Equity ratio is 0.35 whereas as Long-Term Debt/Eq ratio is at 0.35.

On January 02, 2025, Wedbush Downgraded its rating to Underperform which previously was Neutral and also lowered its target price recommendation from $34 to $26.

BMO Capital Markets Downgraded its Outperform to Market Perform on December 09, 2024, whereas the target price for the stock was revised from $34 to $32.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 04 ’24 when Wagner William M sold 35,000 shares for $29.80 per share. The transaction valued at 1,043,000 led to the insider holds 257,439 shares of the business.

Wagner William M bought 35,000 shares of CTRE for $1,044,400 on Sep 04 ’24.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CTRE now has a Market Capitalization of 7693646848 and an Enterprise Value of 7792146944. As of this moment, CareTrust’s Price-to-Earnings (P/E) ratio for their current fiscal year is 28.81, and their Forward P/E ratio for the next fiscal year is 23.04. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.19. For the stock, the TTM Price-to-Sale (P/S) ratio is 20.38 while its Price-to-Book (P/B) ratio in mrq is 2.09. Its current Enterprise Value per Revenue stands at 20.867 whereas that against EBITDA is 24.862.

Stock Price History:

The Beta on a monthly basis for CTRE is 0.86, which has changed by 0.18247175 over the last 52 weeks, in comparison to a change of 0.13054323 over the same period for the S&P500. Over the past 52 weeks, CTRE has reached a high of $34.50, while it has fallen to a 52-week low of $24.79. The 50-Day Moving Average of the stock is 10.29%, while the 200-Day Moving Average is calculated to be 19.52%.

Shares Statistics:

For the past three months, CTRE has traded an average of 2.30M shares per day and 5172570 over the past ten days. A total of 220.30M shares are outstanding, with a floating share count of 219.06M. Insiders hold about 0.56% of the company’s shares, while institutions hold 89.47% stake in the company. Shares short for CTRE as of 1753920000 were 6810521 with a Short Ratio of 2.96, compared to 1751241600 on 5303991. Therefore, it implies a Short% of Shares Outstanding of 6810521 and a Short% of Float of 4.42.

Dividends & Splits

According to the company, the forward annual dividend rate for CTRE is 1.18, from 1.25 in the trailing year. Against a Trailing Annual Dividend Yield of 0.036432527The stock’s 5-year Average Dividend Yield is 4.92.

Earnings Estimates

Current recommendations for the stock of the company come from 3.0 analysts. The consensus estimate for the next quarter is $0.4, with high estimates of $0.47 and low estimates of $0.36.

Analysts are recommending an EPS of between $1.8 and $1.48 for the fiscal current year, implying an average EPS of $1.64. EPS for the following year is $1.7, with 3.0 analysts recommending between $2.05 and $1.44.

Revenue Estimates

A total of 1 analysts believe the company’s revenue will be $120.9M this quarter.It ranges from a high estimate of $120.9M to a low estimate of $120.9M. As of the current estimate, CareTrust REIT Inc’s year-ago sales were $77.38MFor the next quarter, 1 analysts are estimating revenue of $125.4M. There is a high estimate of $125.4M for the next quarter, whereas the lowest estimate is $125.4M.

A total of 2 analysts have provided revenue estimates for CTRE’s current fiscal year. The highest revenue estimate was $453.3M, while the lowest revenue estimate was $341.5M, resulting in an average revenue estimate of $397.4M. In the same quarter a year ago, actual revenue was $296.29MBased on 4 analysts’ estimates, the company’s revenue will be $472.06M in the next fiscal year. The high estimate is $540.4M and the low estimate is $361.1M.

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.